📝 Riddhi Siddhi Gluco Biols Ltd — results explained
Quarter ended June 2026 (Q1 FY27)
Riddhi Siddhi Gluco Biols Ltd reported revenue of ₹80 crore for the quarter ended June 2026 (Q1 FY27), down 44.9% from ₹145 crore in the same quarter last year, and up 6692.1% sequentially over the March 2026 quarter.
Net profit fell 26.3% year-on-year to ₹14 crore, from ₹18 crore. Earnings per share (EPS) came in at ₹18.94.
Operating profit stood at ₹-2 crore — an operating margin (OPM) of -2.4%, compared with -0.9% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Riddhi Siddhi Gluco Biols Ltd posted revenue of ₹203 crore, a growth of 122.3% over FY25, with a net profit of ₹56 crore (down 40.2% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹138 crore with a net profit of ₹51 crore.
Valuation snapshot
At the current price of ₹733.80, 524480 has a market capitalisation of ₹514 crore and a trailing P/E of about 10.0.
Within the Trading & Distributors industry, it is the 13th-largest of the 178 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 75.00%, foreign institutional investors (FIIs) 2.67%, domestic institutional investors (DIIs) 0.01%, public shareholders 22.30% of Riddhi Siddhi Gluco Biols Ltd.
Promoter holding slipped from 86.55% to 75.00% over the latest period.